Colossal Biosciences Raises $120M for Dodo Revival

Colossal Biosciences Raises $120M for Dodo Revival

Colossal Biosciences, led by Ben Lamm and George Church, raised $120 million to advance dodo bird de-extinction at its headquarters, boosting its Series C round to $320 million.

This funding elevates Colossal’s valuation to $10.3 billion yet remains unconnected to cryptocurrency or blockchain, reflecting shifting investment trends toward innovative biotech fields.

Colossal Biosciences has successfully raised $120 million to support its initiative to revive the dodo bird. This fundraising effort brings the company’s Series C round to a total of $320 million.

Founders Ben Lamm and George Church lead the dodo de-extinction initiative with significant backing from high-profile investors. The company’s focus is on advancing avian genetics to achieve this goal. Ben Lamm, CEO of Colossal Biosciences, noted, “Our progress in building the tools needed for de-extinction has been met with incredible support from the investment community.”

$120M Boost Fuels Dodo Bird Revitalization Effort

Colossal’s Valuation Hits $10.3B with New Funding

The funding round enhances Colossal’s valuation to $10.3 billion, marking a critical milestone in biotech financing. Key industry players and investors continue to show substantial support for the company’s ambitious objectives.

While there is no direct impact on cryptocurrency markets or assets, this event spotlights the intersection of biotech innovation and traditional investment channels. Beth Shapiro, Chief Science Officer at Colossal Biosciences, described the initiative as a “transformative tool for avian conservation.”

Biotech Funding Surges Without Crypto Ties

Previous funding rounds in biotech ventures, similar to Colossal’s $200M and $225M, show consistent results without crypto market ties. Historical data underscores steady growth in biotech investments.

Expert insights highlight the lack of cryptocurrency intersection in Colossal’s operations, affirming a traditional investment path. This reflects broader trends in financing biological science advancements over crypto-linked methods.

Disclaimer: This website provides information only and is not financial advice. Cryptocurrency investments are risky. We do not guarantee accuracy and are not liable for losses. Conduct your own research before investing.